Lorundrostat Shows Promise as New Hypertension Treatment Option
New research presented at the American College of Cardiology Scientific Session 2025 suggests that lorundrostat, an investigational drug, can effectively lower blood pressure in patients with uncontrolled and resistant hypertension. A phase 2b study, ADVANCE-HTN, evaluated the efficacy and safety of lorundrostat as add-on therapy to standard treatment for patients who remain hypertensive despite taking … Read more